Replies to post #12567 on Ariad Pharmaceuticals Inc fka ARIA

[Whosetosay]

Good question, I don't know, anybody?

[iandy]

Ariad was XBIs top holding in June.

>The SPDR» S&P» Biotech ETF (the “Fund”) seeks to replicate as closely as possible, before expenses, the
performance of an index derived from the biotechnology segment of a U.S. total market composite index. In
seeking to track the performance of the S&P Biotechnology Select IndustryTM Index (the “Index”), the Fund
employs a replication strategy.<

https://www.spdrs.com/library-content/public/SST%20Equity%20Annual_6.30.11.pdf?fund=XBI&docname=Annual%20Report&onyx_code1=1298&onyx_code2=2099


I have no familiarity with their predictive ratings methodology.
I imagine you would have to ask them.